Skip to content
Clinical Trials – home
GermanyBack to Germany

Clinical trials in Cottbus – page 5

68 clinical trials in Cottbus, Germany across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

GermanyOur site in GermanyKlinischeStudien.de(opens in a new tab)
Cottbus at a glance
68
clinical trials
  • Research sites1
Type of trial
Recruitment status
Quick filters

68 trials in Cottbus

Open in trial search
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Bortezomib
  • Sponsor:Universitaetsklinikum Heidelberg AöR
Countries:GermanyGermany
  • Participants:0–17 years · 18–64 years
  • Substances:Idursulfase
  • Sponsor:Denali Therapeutics Inc.
Countries:GermanyGermany
  • Participants:18–64 years
  • Substances:(2R)-N-[3-(5-Fluoro-2-{[2-Fluoro-3-(Methylsulfonyl)Phenyl]Amino}-4-Pyrimidinyl)-1H-Indol-7-Yl]-3-Methoxy-2-(4-Methyl-1-Piperazinyl)Propanamide-1-Hydroxy-2-Naphthoic Acid
  • Sponsor:AstraZeneca AB

Asthma

Not recruiting
Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Budesonide
  • Sponsor:Areteia Therapeutics Inc.
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Capecitabine
  • Sponsor:Technische Universitaet Dresden
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Cyclophosphamide
  • Sponsor:Incyte Corp.

Bronchiectasis

Not recruiting
Investigational
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Itepekimab
  • Sponsor:Sanofi-Aventis Recherche & Developpement
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Bortezomib
  • Sponsor:Janssen Cilag International
Countries:GermanyGermany
  • Participants:0–17 years
  • Substances:Blinatumomab
  • Sponsor:Universitaetsklinikum Schleswig-Holstein AöR
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Bimekizumab
  • Sponsor:UCB Biopharma
Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Apixaban
  • Sponsor:Celgene Corp.
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Anastrozole
  • Sponsor:Novartis Pharma AG

Other cities in Germany

The busiest research cities in the country

All 516 cities in Germany

Clinical research in Cottbus

What the registry says about research in the country

01 Oncology Research

Innovative clinical trials focusing on breast cancer treatments, including studies of abemaciclib and ribociclib in combination with endocrine therapy. Research also encompasses lymphoma and multiple myeloma treatments.

  • Early-stage breast cancer therapies
  • B-cell lymphoma treatments
  • Multiple myeloma interventions

Advanced trials evaluating targeted therapies and immunotherapy approaches for various cancer types.

02 Respiratory Medicine

Comprehensive studies examining treatments for asthma and COPD, including evaluation of novel inhaler combinations and biological therapies.

  • Severe asthma management
  • Bronchiectasis treatments
  • COPD interventions

Investigations into both maintenance therapies and acute treatment options for respiratory conditions.

03 Rare Diseases

Specialized research focusing on Mucopolysaccharidosis Type II (Hunter Syndrome) and other rare genetic conditions, evaluating novel therapeutic approaches.

  • Enzyme replacement therapies
  • CNS-targeted treatments
  • Long-term safety studies

Emphasis on developing treatments that can cross the blood-brain barrier and address both somatic and CNS symptoms.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.